A team of researchers led by Duke University, the University of California San Francisco, and the Beckman Research Institute ...

Nxera Pharma has entered a collaboration and licensing agreement with Antiverse to design antibodies for GPCRs.

Tokyo, Japan and London and Cardiff, UK, 5 November 2024 – (“Nxera”; TSE 4565) – formerly known as Sosei Group or Sosei ...

NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced the completion of the last patient last visit in ...

Nxera Pharma & Antiverse collaborate to design novel GPCR-targeted antibody therapeutics using generative AI: Tokyo, Japan Wednesday, November 6, 2024, 13:00 Hrs [IST] Nxera Pharm ...

With their unique structure, nanodiscs improve drug delivery and vaccine development, stabilizing membrane proteins for effective therapeutic applications.

AKT signaling pathway is one of the most critical and extensively investigated signaling pathways. It is the central ...

Japan’s Nxera Pharma (TYO: 4565) – formerly known as Sosei – and Antiverse, a UK techbio company designing antibodies for challenging targets, have today announced a multi-target partnership and ...

Peking University-led researchers have modified an existing treatment for liver disease that does not cause itchiness, a ...

Septerna's protracted initial public offering (IPO) on the Nasdaq has finally reached its conclusion, with the final amount ...

It also reduces your appetite by slowing stomach emptying and interacting with receptors in the brain associated with feeling ...

Scientists investigating animal viruses with potential to infect humans have identified a critical protein that could enable spillover of a family of organisms called arteriviruses. In a new study, ...